Association between inappropriate empirical antimicrobial therapy and mortality in gram-negative bloodstream infections in patients with febrile neutropenia and hematological malignancy

被引:1
作者
Riano, Ariel Fernando Florez [1 ]
Castro, Oscar Julian Rojas [1 ]
Ospina, Sigifredo [2 ]
Ramirez-Sanchez, Isabel Cristina [3 ]
机构
[1] Univ Antioquia, Fac Med, Infect Dis, Medellin, Colombia
[2] Univ Antioquia, Clin Epidemiol, Fac Med, Medellin, Colombia
[3] Univ Antioquia, Hosp Pablo Tobon Uribe, Internal Med Dept, Infect Dis Sect,Fac Med, Medellin, Colombia
关键词
Bloodstream infection; Febrile neutropenia; Gram-negative bacilli; Carbapenem resistance; Mortality; Empirical treatment; Inappropriate therapy; KLEBSIELLA-PNEUMONIAE; RESISTANT ENTEROBACTERIACEAE; RISK-FACTORS; SUSCEPTIBILITY; EPIDEMIOLOGY; COMBINATION; EMERGENCE; BACTERIA; CULTURES; OUTCOMES;
D O I
10.1016/j.jiac.2024.10.006
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background and objective: Inappropriate initial antimicrobial therapy has been associated with high mortality in patients with gram-negative bacilli bloodstream infections during febrile neutropenia following chemotherapy for hematological malignancies. The aim of this study is to determine this association in our hospital. Methods: A single center, retrospective, cohort study of bloodstream infection due to gram-negative bacilli and febrile neutropenia was conducted. Clinical characteristics, microbiological etiology, antimicrobial resistance profile, empirical and targeted antibiotic therapy, intensive care unit admission, persistent bacteremia and mortality were analyzed. Results: Of the 171 episodes of bloodstream infection due to gram-negative bacilli, empirical antimicrobial therapy was inappropriate in 43 episodes (25.1 %). There was a significant difference in mortality at 7 and 30 days between patients who received appropriate versus inappropriate empirical treatment (4.6 % versus 13.9 %, p = 0.04; 15.6 % versus 32.5 %, p = 0.016). Inappropriate empirical treatment (RR, 2.97 [95 % CI, 1.01-8.74]), shock at the time of febrile neutropenia diagnosis (RR, 6.5 [95 % CI, 1.83-23.05]) carbapenem-resistant microorganism (RR, 3.73 [95 % CI, 1.14-12.24]) and persistent bacteremia (RR, 84.6 [95 % CI, 11.3-629.4]) were associated with an increased mortality at 7 and 30 days. In the multivariate analysis, shock (RR, 4.85 [95 % CI, 2.10-11.65]) was independently associated with increased 30-day mortality, but inappropriate empirical antimicrobial therapy was not an independent prognostic determinant (RR, 1.66 [0.53-4.82]). Conclusion: Shock at the time of febrile neutropenia diagnosis contributes to mortality in patients with gramnegative bacilli bloodstream infection, in this scenario, appropriate empirical antimicrobial therapy should be encouraged.
引用
收藏
页数:7
相关论文
共 47 条
[1]  
Alhazzani W, 2021, Intensive Care Med, V47, P1181, DOI [DOI 10.1007/S00134-021-06506-Y, 10.1007/s00134-021-06506-y]
[2]   Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study [J].
Andria, Nizar ;
Henig, Oryan ;
Kotler, Offer ;
Domchenko, Alexander ;
Oren, Ilana ;
Zuckerman, Tsila ;
Ofran, Yishai ;
Fraser, Drora ;
Paul, Mical .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (11) :3146-3153
[3]   Persistent Gram-negative Bloodstream Infection Increases the Risk of Recurrent Bloodstream Infection With the Same Species [J].
Ankrah, Paa Kwesi ;
Bock, Andrew ;
Ruffin, Felicia ;
Hanson, Blake M. ;
Arias, Cesar A. ;
Maskarinec, Stacey A. ;
Parsons, Joshua ;
Fowler, Vance G. ;
Thaden, Joshua T. .
CLINICAL INFECTIOUS DISEASES, 2024, 78 (06) :1458-1461
[4]  
[Anonymous], 2021, NICE guideline NG203
[5]   Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing [J].
Banerjee, Ritu ;
Teng, Christine B. ;
Cunningham, Scott A. ;
Ihde, Sherry M. ;
Steckelberg, James M. ;
Moriarty, James P. ;
Shah, Nilay D. ;
Mandrekar, Jayawant N. ;
Patel, Robin .
CLINICAL INFECTIOUS DISEASES, 2015, 61 (07) :1071-1080
[6]   Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis [J].
Bar-Yoseph, Haggai ;
Hussein, Khetam ;
Braun, Eyal ;
Paul, Mical .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (10) :2729-2739
[7]   Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia [J].
Ben-Chetrit, Eli ;
Eldaim, Mustafa Abed ;
Bar-Meir, Maskit ;
Dodin, Mutaz ;
Katz, David E. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 53 (04) :423-428
[8]   The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies [J].
Calik, Sebnem ;
Ari, Alpay ;
Bilgir, Oktay ;
Cetintepe, Tugba ;
Yis, Reyhan ;
Sonmez, Ufuk ;
Tosun, Selma .
SAUDI MEDICAL JOURNAL, 2018, 39 (09) :878-885
[9]   A practical update on the epidemiology and risk factors for the emergence and mortality of bloodstream infections from real-world data of 3014 hematological malignancy patients receiving chemotherapy [J].
Chen, Shaozhen ;
Lin, Kangni ;
Li, Qian ;
Luo, Xiaofeng ;
Xiao, Min ;
Chen, Minmin ;
Zhu, Haojie ;
Chen, Yongquan ;
Wu, Xueqiong ;
Zeng, Yanling ;
Zhang, Yuxin ;
Ally, Issa Hajji ;
Xu, Jingjing ;
Ren, Jinhua ;
Chen, Zhizhe ;
Hu, Jianda ;
Yang, Ting .
JOURNAL OF CANCER, 2021, 12 (18) :5494-5505
[10]  
Chumbita M, 2022, ANTIMICROB AGENTS CH, V66, DOI [10.1128/aac.01744-21, 10.1128/AAC.01744-21]